SPY
772.04
QQQ
745.40
BTC/USD
82,919.34
−1.81%
DIA
517.72
GLD
393.05
TLT
79.38
US
Sign in
Register
My Account
Benzinga
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Personal Finance
Finance
Premium
Menu
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Personal Finance
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Stock Trading Ideas
S&P 500 in the 'Sweet Spot' for Q4: Ryan Detrick Points to 'Above Average Returns,' Noting Gains in 18 of Last 21 Historical Setups
Dow Rises Sharply as Oil Retreats: Investor Sentiment Improves, but Greed Index Remains in ‘Fear’ Zone
Stock Market: Will S&P 500 Open Up or Down Today?
Dow Rises Sharply as Oil Retreats: Investor Sentiment Improves, but Greed Index Remains in ‘Fear’ Zone
Stock Market: Will S&P 500 Open Up or Down Today?
Jefferies Financial, Vail Resorts and 3 Stocks to Watch Heading Into Monday
94% of Warren Buffett's Fortune Came After Age 60 — 7 Lessons From the Retiring Oracle of Omaha
Jefferies Financial, Vail Resorts and 3 Stocks to Watch Heading Into Monday
94% of Warren Buffett's Fortune Came After Age 60 — 7 Lessons From the Retiring Oracle of Omaha
Benzinga's 'Stock Whisper' Index: Five Stocks Investors Secretly Monitor But Don't Talk About Yet
Delta Air Lines Stock Rises Friday: What's Going On?
Read More...
Trading Ideas Recent News
American Airlines Stock Climbs Friday: What's Happening?
American Airlines Group shares are rising Friday as easing Mideast geopolitical tensions drive down global crude oil and jet fuel prices.
Dow Stock Drops Following UBS Price Target Cut
Dow shares are falling Friday after a Wall Street price target cut underscored ongoing margin pressures in global commodity chemicals sector.
This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday
Analysts upgraded First Financial, 3M, Synopsys, Humana and Stem, raising targets for four while maintaining Stem’s $7 target.
This Nike Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Analysts downgraded Nike, Comcast, Restaurant Brands.
TD Synnex Analysts Boost Their Forecasts After Q3 Results
TD SYNNEX beat Q3 estimates with EPS up 59% and revenue up 38%, issued strong Q4 guidance; Morgan Stanley and UBS raised targets.
Crude Oil Down Over 2%; US Consumer Sentiment Eases In September
U.S. stocks climbed Friday: Dow +0.85%, Nasdaq +0.55%, S&P 500 +0.50%. Tech led, energy lagged; sentiment hit 48.1, oil fell 2.5%.
Planet Labs’ Latest Pelican Satellite Heads to SpaceX Launch
Planet Labs shares traded higher after Pelican-12 arrived at Cape Canaveral ahead of its launch aboard SpaceX’s Bandwagon-5 rideshare mission.
Memory Inflation Is Hitting Costco’s Electronics Business, and It Triggered a $152 Million Charge
Costco (COST) stock rose after beating Q4 earnings with $6.75 EPS. Analysts update price targets following strong results.
Squeeze Watch: 10 Stocks With Over 33% Short Interest
Ten stocks have over 34% of their float short, with ONDS and BROS on the list led by VG.
CrowdStrike Stock Slides Amid Akamai's $11.6 Billion Deal
CrowdStrike Holdings shares are dipping Friday as cybersecurity stocks decline following Akamai's $11.6 billion cloud deal with Anthropic.
Why Deep Out Of The Money Silver Calls Look Attractive Now
Whether Your Focus is on the Fed, China or Global Demand, Expect Pressure to Stay on Silver Prices through End of 2026.
Prime Medicine Gets FDA Green Light for Gene Editing Study
The FDA clears Prime Medicine’s IND application for PM647, an investigational in vivo Prime Editor for AATD, for human trials.
Firefly Neuroscience and Neurosigma Partner To Expand Non-Drug Pediatric ADHD Care
Firefly Neuroscience partners with NeuroSigma to expand access to the FDA-cleared Monarch eTNS non-drug ADHD treatment nationwide.
Privacy Manager
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Don't Miss Your Free Daily Briefing!
Subscribe to Benzinga’s free daily market updates and get all the major investing news and best stock picks in your inbox every morning!
Every Story That Matters Around The Web
Trump to Reportedly Make Oval Office Announcement on Monday Afternoon
SCHD ETF Falls to a Crucial Level as Bottoming Signs Emerge - Schwab US Dividend Equity ETF (ARCA:SCHD) - Benzinga
Iran’s Ghalibaf Reaffirms Control Over Strait of Hormuz, Touts $50 Premium on Oil Since the Beginning of War: ‘US Narrative Laundromat…’
Stock Market: Will S&P 500 Open Up or Down Today? - State Street SPDR S&P 500 ETF Trust (ARCA:SPY) - Benzinga
Gavin Newsom Takes a Dig at President as He Bans California Officials from Issuing Memecoins: 'The Scam That is Donald Trump'